SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 133.64 |
| Enterprise Value ($M) | 71.88 |
| Book Value ($M) | 278.77 |
| Book Value / Share | 3.94 |
| Price / Book | 0.48 |
| NCAV ($M) | 267.08 |
| NCAV / Share | 3.78 |
| Price / NCAV | 0.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -0.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 23.52 |
| Current Ratio | 23.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 289.41 |
| Assets | 301.10 |
| Liabilities | 22.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Flynn James E | 9.50 | 89.60 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 0.00 | -98.45 | |
| 13G/A | Vanguard Group Inc | 4.90 | 0.00 | |
| 13D/A | NSV Investments I, L.P. | 10.10 | -15.84 | |
| 13G/A | Citadel Advisors Llc | 7.30 | ||
| 13G | BlackRock, Inc. | 6.50 | ||
| 13G | Tang Capital Partners Lp | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 333,196 | 2,063,418 | 16.15 | |
| 269,275 | 1,093,701 | 24.62 | |
| 292,788 | 888,846 | 32.94 | |
| 262,933 | 1,112,358 | 23.64 | |
| 279,149 | 1,349,433 | 20.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VOR – Vor Biopharma Inc. | VRTX – Vertex Pharmaceuticals Incorporated |
| VTRS – Viatris Inc. | VYGR – Voyager Therapeutics, Inc. |
| XBIT – XBiotech Inc. |
Financial data and stock pages provided by
Fintel.io